What is better Picatic or Configio? If you wish to get a easy way to learn which Event Management Software product is better, our proprietary method gives Picatic a score of 8.4 and Configio a score of 8.5 for total quality and performance. At the same time, Picatic is rated at 88%, while Configio is rated 100% for their user satisfaction level.
You can also compare their product details, such as functions, tools, options, plans, pricing, and many more. Check if the software lets you to customize a few of its processes to make sure it complements your own business procedures.
At this time, the best products in our Event Management Software category are: Eventbrite, monday.com, Cvent.
Configio offers five enterprise pricing plans for users to choose from, and a variety of add-ons they can use to extend the system’s functionality. Give the details a look, and select the best option for your business:
Please keep in mind that while both Picatic and Configio may offer an outstanding array of features each product may be designed for a different company size. If you are comparing features you should pay attention to a business type they are aimed at. Certain elements might scale up efficiently for large enterprises but if you own a small or medium company it’s frequently more sensible to refrain paying for complex features that you might never use.
Page last modified
Why is FinancesOnline free?
FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.
